Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging

Overview

This article presents a method for establishing luciferase-modified human brain tumor xenografts in athymic mice through intracranial injection. The technique allows for monitoring tumor growth and treatment response via bioluminescence imaging, providing valuable insights for pre-clinical brain tumor therapy testing.

Key Study Components

Area of Science

• Neuro-oncology
• Pre-clinical research
• Bioluminescence imaging

Background

• Traditional models used subcutaneous tumor injections.
• Intracranial injections better mimic human brain tumor environments.
• Bioluminescence imaging aids in real-time monitoring of tumor dynamics.
• Understanding drug access to the brain is crucial for therapy development.

Purpose of Study

• To establish a reliable model for studying human brain tumors in mice.
• To evaluate the efficacy of experimental therapies.
• To monitor tumor growth and treatment response accurately.

Methods Used

• Creation of a skull opening for tumor cell injection.
• Preparation of tumor cells from human brain tumor lines.
• Use of bioluminescence imaging for monitoring.
• Survival analysis and histopathological assessments.

Main Results

• Successful establishment of intracranial tumors in mice.
• Effective monitoring of tumor growth using bioluminescence.
• Data supports the evaluation of therapeutic agents.
• Method demonstrates potential for translational research in neuro-oncology.

Conclusions

• The described method enhances the study of brain tumors in pre-clinical settings.
• Bioluminescence imaging is a powerful tool for assessing treatment efficacy.
• This approach may lead to improved therapies for brain tumor patients.

Frequently Asked Questions